Bliss GVS Pharma Ltd NSE:BLISSGVS:
BLISS GVS PHARMA LTD - INCORPORATES THERALIFE PHARMA IN KENYA
Bliss GVS Pharma Incorporates Theralife Pharma In Kenya
Bliss GVS Pharma Limited on 6ix
Earlier from Bliss GVS Pharma
- Bliss GVS Pharma Sept-Quarter Consol Net Profit 272.5 Million Rupees
- Bliss Gvs Pharma Receives Tax Demand Of 166.9 Million Rupees From Tax Department
- Bliss GVS Pharma Ltd - Appoints Narsimha Shibroor Kamath As CEO
- BLISSGVS: Strong Q1 FY26 growth in revenue and profit, with key subsidiary divestment completed
- Bliss GVS Pharma June-Quarter Consol Net Profit 430.4 Million Rupees
Later from Bliss GVS Pharma
- Bliss GVS Pharma board approves appointment of S.N. Kamath as Managing Director
- BLISSGVS: Q3 FY26 net profit reached ₹2,477.91 lakh; interim dividend of 0.50 paisa per share declared
- BLISSGVS: Double-digit revenue and profit growth, strong margins, and expansion in global markets
- Anupam Rasayan enters formulations business with ₹1,369 cr Bliss GVS Pharma acquisition
- Bliss GVS hits 20% upper circuit as Anupam Rasayan to acquire up to 43% stake for Rs 1,369 crore
Follow Bliss GVS Pharma into a list and get an email when it puts out news.
Follow Bliss GVS Pharma